ARK Investment Management disclosed in an SEC filing that it reduced its stake in CRISPR Therapeutics AG (CRSP 5.62%) by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback